Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

31

Number of overlapping holdings

67.4%

% of CANC's 46 holdings also in IBB

16.0%

% of IBB's 214 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus IBB)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in IBB
Overlap
REGENERON PHARMACEUTICALS 6.0% 8.5% 6.0%
AMGEN INC 4.4% 8.0% 4.4%
GILEAD SCIENCES INC 3.3% 9.5% 3.3%
ARGENX SE ADR 3.9% 2.5% 2.5%
ILLUMINA INC 3.3% 2.0% 2.0%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IBB
ASTRAZENECA PLC 5.5%
MERCK & CO. INC. 3.9%
CHUGAI PHARMACEUTICAL CO LTD 3.4%
DAIICHI SANKYO CO LTD 3.2%
REVOLUTION MEDICINES, INC. 2.8%
BLUEPRINT MEDICINES CORP. 2.7%
INTELLIA THERAPEUTICS, INC. 2.3%
CELLDEX THERAPEUTICS INC 2.2%
EXACT SCIENCES CORP 2.2%
NOVARTIS AG 2.1%
CANC Underweight Relative to IBB
VERTEX PHARMACEUTICALS INC -7.4%
GILEAD SCIENCES INC -6.2%
IQVIA HOLDINGS INC -4.0%
AMGEN INC -3.6%
ALNYLAM PHARMACEUTICALS INC -3.2%
METTLER-TOLEDO INTERNATIONAL -2.8%
BIOGEN IDEC INC -2.7%
REGENERON PHARMACEUTICALS -2.5%
WATERS CORP -1.9%
BIONTECH SE SPONSORED ADR -1.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY